The Diagnostic Process

The journey to a Fanconi-Bickel Syndrome (FBS) diagnosis often begins with a few puzzling clues: a child who is growing more slowly than expected, a noticeably enlarged belly, or unusual laboratory results during a routine checkup ^[1][2]. Because FBS is extremely rare, reaching a definitive diagnosis requires a combination of clinical evaluation, specialized lab tests, and genetic confirmation.

Clinical and Biochemical Clues

The diagnosis of FBS is supported by a combination of clinical signs and laboratory findings ^[3]. Doctors typically look for:

1. Hepatomegaly and Growth Issues: An enlarged liver and a significant deficit in height or weight gain ^[3][4].
2. A “Leaky” Kidney Pattern: The kidneys fail to reabsorb multiple substances at once. This proximal tubulopathy leads to a specific set of findings on a lab report ^[1].
3. Impaired Galactose Tolerance: While FBS affects glucose, it also affects how the body handles galactose (a sugar in milk). Evidence of impaired galactose handling or galactosuria (galactose in the urine) is a strong clue, though doctors rarely perform a formal “galactose challenge” test due to safety risks ^[3][5].

Deciphering Your Child’s Lab Report

When you look at your child’s medical records, you may see several technical terms that describe what the kidneys are losing:

• Glucosuria: High levels of glucose (sugar) in the urine, even when blood sugar is normal or low ^[6]. This is often the first clue ^[4].
• Phosphaturia: Loss of phosphorus in the urine, which leads to low phosphorus in the blood (hypophosphatemia) and can cause weak bones (rickets) ^[7][1].
• Aminoaciduria: The loss of amino acids, the building blocks of protein ^[1].
• Elevated Transaminases (AST/ALT): High levels of these liver enzymes indicate that the liver is under stress or enlarged. These are clues rather than disease-specific tests, and they can be elevated in many liver conditions ^[2][8].

Genetic Testing: The Final Confirmation

While lab tests suggest FBS, the diagnosis is definitively confirmed through genetic testing. FBS is an autosomal recessive condition, meaning a child must inherit two non-working copies of the SLC2A2 gene ^[4][9].

• Biallelic Pathogenic Variants: The report generally requires finding two disease-causing mutations (variants) in the SLC2A2 gene.
• “In Trans”: Parental testing is often done to confirm that one variant came from the mother and the other from the father, proving they are on opposite copies of the gene.
• Variants of Uncertain Significance (VUS): Sometimes a test finds a variant that isn’t yet known to cause disease. A VUS requires expert interpretation by a metabolic geneticist to determine if it fits the clinical picture.

Genetic Counseling: Because it is autosomal recessive, parents who are carriers have a 25% chance in each future pregnancy of having another child with FBS. A genetic counselor can help you understand these risks and discuss testing for siblings.

Differentiating FBS from Other Conditions

Because its symptoms overlap with other diseases, FBS can sometimes be misdiagnosed initially. For instance, Glycogen Storage Disease Type Ia (GSD Ia) also causes an enlarged liver and low blood sugar. However, GSD Ia typically causes high levels of lactic acid and fats (triglycerides) in the blood ^[10][11]. FBS is uniquely defined by the severe “leakiness” of the kidneys combined with the liver involvement ^[12].

Mild and Atypical Presentations

Not every child will have the severe, classic presentation. Some children have mild phenotypes if their SLC2A2 variants still allow for some residual function of the GLUT2 transporter ^[3]. A child might only show sugar in their urine without having a large liver or severe growth failure ^[13]. This can delay diagnosis until later in childhood ^[4]. Conversely, some infants are initially misdiagnosed with neonatal diabetes because of high blood sugar spikes after meals ^[2].